AbCellera Biologics (ABCL) Shares Outstanding (2020 - 2025)
AbCellera Biologics (ABCL) has disclosed Shares Outstanding for 6 consecutive years, with $299.0 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding rose 1.31% year-over-year to $299.0 million, compared with a TTM value of $299.0 million through Sep 2025, up 1.31%, and an annual FY2024 reading of $295.8 million, up 1.7% over the prior year.
- Shares Outstanding was $299.0 million for Q3 2025 at AbCellera Biologics, roughly flat from $298.7 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $299.0 million in Q3 2025 and bottomed at $270.9 million in Q1 2021.
- Average Shares Outstanding over 5 years is $289.1 million, with a median of $289.5 million recorded in 2023.
- The sharpest move saw Shares Outstanding skyrocketed 13254.71% in 2021, then rose 1.31% in 2025.
- Year by year, Shares Outstanding stood at $281.2 million in 2021, then grew by 2.03% to $286.9 million in 2022, then increased by 1.39% to $290.8 million in 2023, then grew by 1.7% to $295.8 million in 2024, then grew by 1.1% to $299.0 million in 2025.
- Business Quant data shows Shares Outstanding for ABCL at $299.0 million in Q3 2025, $298.7 million in Q2 2025, and $298.4 million in Q1 2025.